News

06 November 2018 – R-Pharm Group and the Specialty Pharma Company PAION AG (ISIN DE000A0B65S3; Frankfurt Stock Exchange Prime Standard:...
read more...
November 6
The IV Eurasian Rheumatology Congress attended by leading healthcare professionals from around the globe was held in Moscow on 26-28...
read more...
September 28
Localization of full cycle production of Kaletra® finished dosage form will help to improve access of Russian patients to antiretroviral...
read more...
July 4
According to the latest Transparency in corporate reporting 2017 research conducted by Transparency international in Russia, R-Pharm was...
read more...
June 4
Marking the Russia-Japan cultural exchange year two countries are ready to announce preliminary achievements of implementation of 8-point...
read more...
May 31
May 25, 2018, in Saint Petersburg a Russian hi-tech pharmaceutical company R-Pharm signed an agreement with FUJIFILM Сorporation on...
read more...
May 25
May 25, 2018, in Saint Petersburg a Russian hi-tech pharmaceutical company R-Pharm Holding signed an agreement with FUJIFILM Corporation on...
read more...
May 25
17 May 2018 – Russian pharmaceutical company R-Pharm and Specialty Pharma Company PAION AG (Aachen, Germany) announced that Phase III trial...
read more...
May 17